Eczema Trial, Recruiting (NCT06313333)

Eczema Trial, Recruiting NCT06313333 Sponsor: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT06313333 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are willing and able to sign a consent form agreeing to take part in the study
You have been diagnosed by a skin specialist (dermatologist) with moderate or severe atopic dermatitis (eczema), based on one of the following: a skin severity score (EASI) of 16 or higher, OR a lower severity score but with eczema affecting a sensitive area such as the face, hands, or genitals, OR a high impact on daily quality of life, OR severe itching, OR severe sleep disruption (confirm with trial site for exact score thresholds)

Who may not be able to join:

You are unable or unwilling to sign a consent form before any data is collected
You are unable to complete the tasks and procedures required by the study
You are already taking part in another follow-up registry or tracking study for the same condition (atopic dermatitis/eczema)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Piergiacomo MD Calzavara Pinton, Asst Degli Spedali Civili Di Brescia

Phone: 0303995305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06313333

Sponsor: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: 0303995305

More information: https://clinicaltrials.gov/study/NCT06313333

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are willing and able to sign a consent form agreeing to take part in the study
You have been diagnosed by a skin specialist (dermatologist) with moderate or severe atopic dermatitis (eczema), based on one of the following: a skin severity score (EASI) of 16 or higher, OR a lower severity score but with eczema affecting a sensitive area such as the face, hands, or genitals, OR a high impact on daily quality of life, OR severe itching, OR severe sleep disruption (confirm with trial site for exact score thresholds)

Who may not be able to join:

You are unable or unwilling to sign a consent form before any data is collected
You are unable to complete the tasks and procedures required by the study
You are already taking part in another follow-up registry or tracking study for the same condition (atopic dermatitis/eczema)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

Registry

ClinicalTrials.gov

Start date

15 June 2020

Est. completion

31 December 2030

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Epidemiological data; Identification of factors for specific treatment; clinical and therapeutic data; characterization of diagnostic criteria; Assessment of possible conditioning factors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov